These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. Airas L; Dickens AM; Elo P; Marjamäki P; Johansson J; Eskola O; Jones PA; Trigg W; Solin O; Haaparanta-Solin M; Anthony DC; Rinne J J Nucl Med; 2015 Feb; 56(2):305-10. PubMed ID: 25572093 [TBL] [Abstract][Full Text] [Related]
49. Radiosynthesis and characterization of [ Lee SH; Denora N; Laquintana V; Mangiatordi GF; Lopedota A; Lopalco A; Cutrignelli A; Franco M; Delre P; Song IH; Kim HW; Kim SB; Park HS; Kim K; Lee SY; Youn H; Lee BC; Kim SE Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):110-124. PubMed ID: 34783879 [TBL] [Abstract][Full Text] [Related]
50. A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Nutma E; Stephenson JA; Gorter RP; de Bruin J; Boucherie DM; Donat CK; Breur M; van der Valk P; Matthews PM; Owen DR; Amor S Brain; 2019 Nov; 142(11):3440-3455. PubMed ID: 31578541 [TBL] [Abstract][Full Text] [Related]
51. Choroid Plexus Enlargement in Inflammatory Multiple Sclerosis: 3.0-T MRI and Translocator Protein PET Evaluation. Ricigliano VAG; Morena E; Colombi A; Tonietto M; Hamzaoui M; Poirion E; Bottlaender M; Gervais P; Louapre C; Bodini B; Stankoff B Radiology; 2021 Oct; 301(1):166-177. PubMed ID: 34254858 [TBL] [Abstract][Full Text] [Related]
52. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects. Varrone A; Oikonen V; Forsberg A; Joutsa J; Takano A; Solin O; Haaparanta-Solin M; Nag S; Nakao R; Al-Tawil N; Wells LA; Rabiner EA; Valencia R; Schultze-Mosgau M; Thiele A; Vollmer S; Dyrks T; Lehmann L; Heinrich T; Hoffmann A; Nordberg A; Halldin C; Rinne JO Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):438-46. PubMed ID: 25412766 [TBL] [Abstract][Full Text] [Related]
53. Exploration of the impact of stereochemistry on the identification of the novel translocator protein PET imaging agent [(18)F]GE-180. Chau WF; Black AM; Clarke A; Durrant C; Gausemel I; Khan I; Mantzilas D; Oulie I; Rogstad A; Trigg W; Jones PA Nucl Med Biol; 2015 Sep; 42(9):711-9. PubMed ID: 26072270 [TBL] [Abstract][Full Text] [Related]
54. Activated microglia by Wang J; Jin L; Zhang X; Yu H; Ge J; Deng B; Li M; Zuo C; Chen X J Neuroimmunol; 2022 Jul; 368():577879. PubMed ID: 35504188 [TBL] [Abstract][Full Text] [Related]
56. Imaging Microglial Activation in Untreated First-Episode Psychosis: A PET Study With [ Hafizi S; Tseng HH; Rao N; Selvanathan T; Kenk M; Bazinet RP; Suridjan I; Wilson AA; Meyer JH; Remington G; Houle S; Rusjan PM; Mizrahi R Am J Psychiatry; 2017 Feb; 174(2):118-124. PubMed ID: 27609240 [TBL] [Abstract][Full Text] [Related]
57. Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760 [TBL] [Abstract][Full Text] [Related]
58. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818 [TBL] [Abstract][Full Text] [Related]
59. PET imaging of [ Varnäs K; Cselényi Z; Jucaite A; Halldin C; Svenningsson P; Farde L; Varrone A Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):367-375. PubMed ID: 30270409 [TBL] [Abstract][Full Text] [Related]